Diamonds and Dogs
7/23/14
Puma Biotechnology Inc. (PBYI)Puma Biotechnology exploded today up 219.82% to $230.51 after a previous close of $59.03. The biotech company saw its shares more than triple after their breast cancer drug neratinib passed its trial's goals in a stage 3 trial. The scenario for Puma and its shareholders was one of the best cases they could have hoped for. The trials for other combinations of neratinib indicate that there may just be more room for the stock to run in the future for Puma.
Tupperware Brands Corp. (TUP)
Tupperware Brands Corporation experienced a dip in today's market, down 10.29% to $76 a share. The American multinational direct sales company headquartered in Orlando, Florida lowered its full year guidance following second quarter postings that were lower than expected. TUP's quarterly profits fell 38% to $47.6 million $1.43 per diluted share while analysts were expecting earnings of $1.47 per share. Analysts still rate the stock as a buy despite today's drop because the strengths of the company will continue to out-weigh the weaknesses.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.